Navigation Links
Diplomat Specialty Pharmacy Sponsors National Managed Care Roundtable for Industry Executive Advisory Board
Date:5/29/2008

SWARTZ CREEK, Mich., May 29 /PRNewswire/ -- Diplomat Specialty Pharmacy, a leader in specialty pharmacy services, disease management (DM) and drug therapy management (DTM) announced today that their specialty pharmacy was one of 3 sponsors of the National Managed Care Roundtable (NMCRT) held this month in Dallas, Texas. This forum brought 30 industry executives from top consulting and managed care organizations together to review and improve on the current offerings and directions of specialty pharmacy and other critical business segments.

"With our advisors high in the managed care hierarchy, their opinions carry weight in their organizations and within the managed care marketplace," stated Jim Smeeding, President of NMCRT. "I believe that Diplomat offered services that go above and beyond the usual expectations for a specialty pharmacy."

"Managed Care executives provided us with invaluable insights at the meeting. Their reviews will benefit us greatly as we continue to expand Diplomat on a national level," stated Phil Hagerman, President and CEO of Diplomat. "Consistent messages from the group included: the importance of patient care outcome reporting, the need for increased price transparency, the benefits of shared risk for disease management, and the need to maintain a high level of service to patients on specialty medications."

"The feedback from managed care organizations confirmed that specialty pharmacy is still a high priority within the pharmacy and medical benefits," stated Dr. Atheer Kaddis, Diplomat's Vice President of Managed Markets. "It also confirmed to us that there are very few, if any, successful care management models addressing kidney disease today. The programs presented by Diplomat Specialty Pharmacy to address specialty pharmacy and kidney disease were well received by managed care organizations and we are excited about future potential opportunities to work with managed care organizations in these priority areas."

Smeeding added that, "Diplomat was very well received by our advisors -- clearly there is an unmet need for managing these high cost, high acuity patients that Diplomat services. The feedback from our advisors should allow Diplomat to continue to expand their offerings with greater insights into what the marketplace demands and desires."

About Diplomat Specialty Pharmacy

Diplomat Specialty Pharmacy is a privately held health care organization focusing on complete medication management programs for patients with serious and chronic conditions. Key programs include: Oncology, HIV/AIDS, Hepatitis C, Multiple Sclerosis, Rheumatoid Arthritis and Psoriasis. Other specialty areas include Transplant, Fertility, Dialysis Medication Management, Bio-Identical Hormone Replacement Therapy and Specialty Compounding. The company's Health Services division specializes in Disease Management programs for Chronic Kidney Disease patients, as well as Home and Out-Patient Infusion. With locations in Flint and Grand Rapids, MI; Cleveland, OH; Chicago, IL; and Ft. Lauderdale, Florida; Diplomat services the specialty pharmacy needs of patients and physicians nationwide.

About NMCRT

Established in 2006, National Managed Care Roundtable LLC (NMCRT) provides innovative, informational interchange programs to address the business and clinical issues of medical directors and pharmacy directors from health plans, pharmacy benefit management companies and physician groups. Typical sponsors include pharmaceutical companies, medical device, disease management and other companies offering products and services of interest to our advisors.

For more information contact:

Alecia Greilich

agreilich@diplomatpharmacy.com

810-720-4452


'/>"/>
SOURCE Diplomat Specialty Pharmacy
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Diplomat Specialty Pharmacy Hires National Accounts Manager to Expand Multiple Sclerosis Program
2. Diplomat Specialty Pharmacy Hires Vice President of Managed Markets
3. Diplomat Specialty Pharmacy Health Services Division Achieves High Marks in Pilot Program for Chronic Kidney Disease Management
4. 60 Specialty Chemical, Fine Chemical & Custom Synthesis Providers Will Exhibit at Pharma ChemOutsourcing on September 8-9 in New Jersey
5. Atrium completes the sale of its Active Ingredients and Specialty Chemicals division
6. West Pharmaceutical Services to Present at the 2008 UBS Global Specialty & Generic Pharmaceuticals Conference
7. Botaneco signs feasibility agreement with Croda to develop specialty crop oil formulation
8. Baxter Adds Recombinant Protein to Specialty Therapeutics Portfolio
9. Patient Treatment for Bipolar Disorder Varies Depending on Doctor Specialty; Well Designed Clinical Trials May Be The Answer
10. Pharmacyclics Announces It Received Nasdaq Notification
11. Pharmacyclics Announces Multiple Presentations at the American Association for Cancer Research Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... , Jan. 18, 2017   Boston Biomedical , ... designed to target cancer stemness pathways, will feature data ... napabucasin, at the 2017 ASCO Gastrointestinal Cancers Symposium, held ... . Napabucasin is an orally-administered investigational ... STAT3. i Cancer stem cells (CSCs) possess the ...
(Date:1/18/2017)... ... 2017 , ... Whitehouse Labs has furthered its efforts towards ... (AMRI), the scientific staff dedicated to Extractables / Leachables & Impurities has more ... 2017. Extractable & Leachable evaluations have become increasingly more vital to successful product ...
(Date:1/18/2017)... ... January 18, 2017 , ... ... to sell research and genetic testing lab equipment from two different leading institutes. This ... and Northeast regions of the United States. This 1-day online auction will take ...
(Date:1/18/2017)... Texas , Jan. 18, 2017  Caris ... and the Lustgarten Foundation, the largest private funder ... a clinical trial evaluating the impact of immunotherapy ... providing clinical trial enrollment services to identify potential ... facilitate communication between treating physicians and study investigators. ...
Breaking Biology Technology:
(Date:12/15/2016)... Calif. , Dec. 15, 2016   WaferGen ... publicly held genomics technology company, announced today that on ... Listing Qualifications Department of The Nasdaq Stock Market LLC ... closing bid price of WaferGen,s common stock had been ... Accordingly, WaferGen has regained compliance with Listing Rule 5550(a)(2) ...
(Date:12/15/2016)... "Increase in mobile transactions is driving the growth of ... expected to grow from USD 4.03 billion in 2015 ... of 29.3% between 2016 and 2022. The market is ... smart devices, government initiatives, and increasing penetration of e-commerce ... to grow at a high rate during the forecast ...
(Date:12/7/2016)... India , December 7, 2016 According to a ... Machine Learning), Software Tool (Facial Expression, Voice Recognition), Service, Application Area, End User, ... is estimated to grow from USD 6.72 Billion in 2016 to USD 36.07 ... Continue Reading ... ...
Breaking Biology News(10 mins):